Down 99%, biotech firm 180 Life Sciences pivots to crypto with ETH bet

The Nasdaq-listed biotechnology firm is raising $425 million for its ETH strategy, joining a parade of penny stocks investing in cryptocurrencies as their business flounders.

Related Posts

Leave a Reply

Recent Articles

Bank of Korea to launch virtual asset committee to monitor crypto
July 30, 2025
AML Bitcoin founder gets 7 years in prison for crypto fraud
July 30, 2025
Kraken seeks $500M at $15B valuation ahead of rumoured 2026 IPO: Report
July 30, 2025

Text Widget

Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.

Post Category